Mark I. McCarthy

266.0k total citations · 13 hit papers
516 papers, 36.4k citations indexed

About

Mark I. McCarthy is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Mark I. McCarthy has authored 516 papers receiving a total of 36.4k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Genetics, 157 papers in Molecular Biology and 119 papers in Surgery. Recurrent topics in Mark I. McCarthy's work include Genetic Associations and Epidemiology (121 papers), Pancreatic function and diabetes (109 papers) and Diabetes and associated disorders (59 papers). Mark I. McCarthy is often cited by papers focused on Genetic Associations and Epidemiology (121 papers), Pancreatic function and diabetes (109 papers) and Diabetes and associated disorders (59 papers). Mark I. McCarthy collaborates with scholars based in United Kingdom, United States and Finland. Mark I. McCarthy's co-authors include Andrew T. Hattersley, Jian Yang, Peter M. Visscher, Matthew A. Brown, Julia Addington‐Hall, Stephen Franks, Timothy M. Frayling, Irene J Higginson, Joel N. Hirschhorn and G. A. Hitman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Mark I. McCarthy

504 papers receiving 35.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

10 Years of GWAS Discovery: Biology, Function, and Translation

2017 2.0k citations Mark I. McCarthy et al. profile →
Genome-wide association studies for complex traits: consensus, uncertainty and challenges

2008 1.9k citations Mark I. McCarthy et al. profile →
Five Years of GWAS Discovery

2012 1.5k citations Mark I. McCarthy et al. profile →
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

2019 1.1k citations Anubha Mahajan, Mark I. McCarthy et al. profile →
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

2006 847 citations Mark I. McCarthy et al. profile →
Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits

2012 736 citations Andrew P. Morris, Mark I. McCarthy et al. profile →
Genomics, Type 2 Diabetes, and Obesity

2010 645 citations Mark I. McCarthy profile →
Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes

2003 538 citations Bridget Knight, G. A. Hitman et al. profile →
Obesity and polycystic ovary syndrome

2006 485 citations Mark I. McCarthy et al. profile →
A brief history of human disease genetics

2020 349 citations Mark I. McCarthy et al. profile →
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2020 224 citations Wendy K. Chung, Karel Erion et al. Diabetes Care profile →
Genetics meets proteomics: perspectives for large population-based studies

2020 223 citations Mark I. McCarthy et al. profile →
Strong Amerind/White Sex Bias and a Possible Sephardic Contribution among the Founders of a Population in Northwest Colombia

2000 74 citations Mark I. McCarthy et al. profile →

Peers

Countries citing papers authored by Mark I. McCarthy

Since Specialization

Citations

This map shows the geographic impact of Mark I. McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark I. McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark I. McCarthy more than expected).

Fields of papers citing papers by Mark I. McCarthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark I. McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark I. McCarthy. The network helps show where Mark I. McCarthy may publish in the future.

Co-authorship network of co-authors of Mark I. McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark I. McCarthy. A scholar is included among the top collaborators of Mark I. McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark I. McCarthy. Mark I. McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review 2024 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), (unknown), Veronica McInerney, Stewart R. Walsh, Aoïfe Lowery, Mark I. McCarthy, Peter J. Carr	3
2	Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy 2023 ·Genome Medicine ·Zia Khan, Min Jung, Megan Crow, (unknown), Vidya Maiya, Joshua S. Kaminker, David H. Hackos, G. Scott Chandler, Mark I. McCarthy, Tushar Bhangale	6
3	Central Adiposity Increases Risk of Kidney Stone Disease through Effects on Serum Calcium Concentrations 2023 ·Journal of the American Society of Nephrology ·Catherine Lovegrove, Jelena Bešević, Akira Wiberg, Ben Lacey, Thomas J. Littlejohns, Naomi E. Allen, Michelle Goldsworthy, Jihye Kim, Fadil Hannan, Gary C. Curhan, Benjamin W. Turney, Mark I. McCarthy, Anubha Mahajan, (unknown), Michael V. Holmes, Dominic Furniss, Sarah Howles	22
4	RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro 2020 ·Nature Communications ·Nellie Y. Loh, James E. N. Minchin, Katherine E. Pinnick, (unknown), Marijana Todorčević, Nathan Denton, Julia S. El-Sayed Moustafa, John P. Kemp, Celia L. Gregson, David M. Evans, Matt J. Neville, Kerrin S. Small, Mark I. McCarthy, Anubha Mahajan, John F. Rawls, Fredrik Karpe, Constantinos Christodoulides	39
5	Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) breakdown → 2020 ·Diabetes Care ·Wendy K. Chung, Karel Erion, José C. Florez, Andrew T. Hattersley, Marie‐France Hivert, Christine G. Lee, Mark I. McCarthy, John J. Nolan, Jill M. Norris, Ewan R. Pearson, Louis H. Philipson, Allison T. McElvaine, William T. Cefalu, Stephen S. Rich, Paul W. Franks	224
6	Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies 2020 ·PLoS Genetics ·Robin N. Beaumont, Sarah J. Kotecha, Andrew R. Wood, Bridget Knight, Sylvain Sebért, Mark I. McCarthy, Andrew T. Hattersley, Marjo‐Riitta Järvelin, Nicholas J. Timpson, Rachel M. Freathy, Sailesh Kotecha	13
7	Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements 2019 ·Nature Communications ·Fiona Allum, Åsa K. Hedman, Xiaojian Shao, Warren Cheung, Jinchu Vijay, Frédéric Guénard, Tony Kwan, Marie-Michelle Simon, Bing Ge, Cristiano Soares de Moura, (unknown), Lars Rönnblom, Sasha Bernatsky, Mark Lathrop, Mark I. McCarthy, Panos Deloukas, André Tchernof, Tomi Pastinen, Marie‐Claude Vohl, Elin Grundberg	10
8	Detection of human adaptation during the past 2000 years 2016 ·Science ·Yair Field, Evan A. Boyle, Natalie Telis, Ziyue Gao, Kyle J. Gaulton, David E. Golan, Loïc Yengo, Ghislain Rocheleau, Philippe Froguel, Mark I. McCarthy, Jonathan K. Pritchard	233
9	Trans-ethnic study design approaches for fine-mapping 2016 ·European Journal of Human Genetics ·Jennifer L. Asimit, Konstantinos Hatzikotoulas, Mark I. McCarthy, Andrew P. Morris, Eleftheria Zeggini	43
10	Childhood cognitive ability moderates later-life manifestation of type 2 diabetes genetic risk. 2015 ·Health Psychology ·René Mõttus, Michelle Luciano, (unknown), Mark I. McCarthy, Ian J. Deary	7
11	Planning elderly and palliative care in Montenegro 2009 ·SHILAP Revista de lepidopterología ·Mark I. McCarthy, (unknown)	0
12	Metabolic Cardiovascular Disease Risk Factors in Women With Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study 2004 ·Obstetrical & Gynecological Survey ·Saara Taponen, Hannu Martikainen, (unknown), Ulla Sovio, Jaana Laitinen, Anneli Pouta, (unknown), Mark I. McCarthy, Stephen Franks, Mika Paldanius, Aimo Ruokonen	12
13	Delayed Metabolic and Thermogenic Response to a Mixed Meal in Normoglycemic European Women with Previous Gestational Diabetes 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Eleni Κousta, Kim H. Parker, Natasha Lawrence, Anna Penny, Barbara A. Millauer, V. Anyaoku, Henrietta Mulnier, (unknown), Ian Macdonald, Stephen T. Robinson, Mark I. McCarthy, Desmond G. Johnston	7
14	Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy 2000 ·Human Molecular Genetics ·Peter Dixon, (unknown), (unknown), (unknown), John C. Chambers, (unknown), J. Weaver, Catherine Nelson‐Piercy, Michael de Swiet, Gary Warnes, Ellen Roy Elias, Christopher F. Higgins, Desmond G. Johnston, Mark I. McCarthy, Catherine Williamson	5
15	Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease 1995 ·Diabetologia ·G. A. Hitman, K. Hawrami, Mark I. McCarthy, Viswanathan Mohan, C. Snehalatha, (unknown), (unknown), Eva Tuomilehto‐Wolf, Aulikki Nissinen, Oluf Pedersen	11
16	In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk 1995 ·Diabetologia ·Kelly Metcalfe, G. A. Hitman, Michael Fennessy, Mark I. McCarthy, (unknown), (unknown)	1
17	Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease 1995 ·Diabetologia ·G. A. Hitman, K. Hawrami, Mark I. McCarthy, Viswanathan Mohan, Chamukuttan Snehalatha, (unknown), J. Tuomilehto, Eva Tuomilehto‐Wolf, Aulikki Nissinen, Oluf Pedersen	94
18	In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk 1995 ·Diabetologia ·Kelly Metcalfe, G. A. Hitman, Michael Fennessy, Mark I. McCarthy, Jaakko Tuomilehto, Eva Tuomilehto‐Wolf, (unknown)	25
19	Family studies of non-insulin-dependent diabetes mellitus in South Indians 1994 ·Diabetologia ·Mark I. McCarthy, G. A. Hitman, Denis C. Shields, Newton E. Morton, Chamukuttan Snehalatha, Viswanathan Mohan, Anupama Ramachandran	24
20	Epidemiology and policies for health planning 1982 ·OpenGrey (Institut de l'Information Scientifique et Technique) ·Mark I. McCarthy	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact